Skip to main content
. 2021 Apr 12;5(7):2003–2011. doi: 10.1182/bloodadvances.2020002701

Figure 1.

Figure 1.

Identification of the best available donor based on KIR genotypes, using the weighted tiered algorithm in all evaluated patients. Recipients with >1 donor are divided based on KIR ligand: HLA-C1+/HLA-Bw4+ recipients had donors prioritized for KIR3DL1 inhibition, followed by KIR2DS1, and then cenBB. HLA-C1+/HLA-Bw4 recipients had donors prioritized for KIR2DS1, followed by cenBB.